Retinadoc, Mathew Herper & Adam Feuerstein initially came out with their MO
narrative right after R-I Results were officially presented. It's the same people
who put this garbage out repeatedly. Seems obvious to any logical observer
that they have an "agenda." Obviously, the goal is to crush AMRN but why?
At one point Adam Feuerstein was calling JT & AMRN both "tired" and
suggested that JT become a "Wall-Street Hero" by selling AMRN to a BP.
He even suggested Amgen as one example. At another point Dr. Nissen
decided that Vascepa was a good drug, but that was short lived. As everyone
on this knows it has always been my contention that Vascepa had to be owned
by BP for a multitude of reasons...Protection, marketing, distribution, etc.
A GIA strategy never made any sense to me for reasons that are all too
obvious. I always thought that BP could make a good deal of money
from Vazkepa in Europe. Unfortunately, Germany is not working out
very well. Would results have been better if AMRN had been owned
by Roche, Bayer, or Novartis? (Call it a "wild guess" but I think it would
have done better...Maybe, a lot better!
News 
Market Data 
Discover 
